2-Amino-5-bromo-N-cyclopropylnicotinamide

Catalog No. :
ACQCWN620
CAS No. :
781642-04-4
Molecular Formula :
C9H10BrN3O
Molecular Weight :
256.10

IUPAC Name:2-amino-5-bromo-N-cyclopropylnicotinamide

2-Amino-5-bromo-N-cyclopropylnicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$104.00Login to see priceIn stockInquiry
1g97%$281.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-5-bromo-N-cyclopropylnicotinamide
IUPAC Name2-amino-5-bromo-N-cyclopropylnicotinamide
MDL No.MFCD16688762
Molecular FormulaC9H10BrN3O
Molecular Weight256.10
SMILESO=C(NC1CC1)C2=C(N)N=CC(Br)=C2
InChI KeyXQDUHXXXKDOOLP-UHFFFAOYSA-N
Synonym3-Pyridinecarboxamide,2-amino-5-bromo-N-cyclopropyl-(9CI);2-Amino-5-bromo-N-cyclopropyl-nicotinamide;3-Pyridinecarboxamide, 2-amino-5-bromo-N-cyclopropyl-
CAS No.781642-04-4
PubChem CID45086968

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQCWN620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  2. Plus
  3. ACSJNE538 route compound structure diagram
    ACSJNE53852963-33-4 In Stock
  4. Then
  5. ACQCWN620 route product structure diagram
    ACQCWN620781642-04-4 In Stock
Inquiry

2. ACQCWN620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIEKO845 route compound structure diagram
    ACIEKO845433226-06-3 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACQCWN620 route product structure diagram
    ACQCWN620781642-04-4 In Stock
Inquiry

Comments (0)